Latham & Watkins (San Francisco)

Kelly Smith Fayne

Latham & Watkins (San Francisco)
Lawyer (Associate)

Kelly Smith is an associate in the firm’s antitrust and competition practice group where her practice includes representing clients in antitrust litigation, government reviews of mergers and acquisitions, filing obligations under the Hart-Scott-Rodino Act, government investigations, and counseling clients in relation to antitrust issues. Ms. Smith graduated from the University of Chicago Law School in 2009. Prior to entering law school, she worked as an analyst for a major economic consulting firm where she focused on government review of mergers and acquisitions, antitrust litigation, and intellectual property. Ms. Smith has represented clients in a variety of industries including manufacturing, pharmaceuticals, financial services, telecommunications, and consumer retail products.


Linked authors

Latham & Watkins (Brussels)
Latham & Watkins (Paris)
Latham & Watkins (San Francisco)
Latham & Watkins (Hambourg)
Latham & Watkins (Brussels)


281 Bulletin

Diane E. Bieri, Jonathan Gleklen, Kelly Smith Fayne, Tim Frazer The US Supreme Court holds that “reverse payment” patent settlements between brand-name drug manufacturers and would-be generic competitors should be reviewed under the antitrust rule of reason (Actavis)


On Monday, June 17, the Supreme Court handed down a decision in FTC v. Actavis, Inc., bringing some clarity to the antitrust treatment of so-called reverse payment patent settlements between brand-name drug manufacturers and would-be generic competitors, but leaving many open questions as (...)

Send a message